Chattanooga Neurology Associates (Erlanger Hospital)
Chattanooga, Tennessee, United States
Neurologist in Chattanooga, Tennessee
979 E 3rd St Suite C-830, Chattanooga, TN 37403
About Chattanooga Neurology Associates (Erlanger Hospital)
"Erlanger’s neurology specialists treat adult and pediatric patients with a variety of neurological disorders ranging from the common to the complex. As a certified academic Neurosciences Center, we provide a comprehensive, multidisciplinary approach to care, giving our patients access to more specialty and subspecialty services than any area health system."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Chattanooga Neurology Associates (Erlanger Hospital)
During the past decade, Chattanooga Neurology Associates (Erlanger Hospital) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men
2004-04-01
2007-08-01
Completed
288
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
2007-05-15
2018-05-14
Terminated
836
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis
2007-10-31
2011-01-31
Completed
132
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
2009-09-01
2012-12-01
Completed
201
Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
2009-09-01
2010-09-01
Completed
99
A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections
2009-11-17
2011-03-01
Terminated
679
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Chattanooga Neurology Associates (Erlanger Hospital)"
#1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Chattanooga Neurology Associates (Erlanger Hospital)
According to Clinical.Site data, the most researched conditions in "Chattanooga Neurology Associates (Erlanger Hospital)" are
"Acute Ischemic Stroke" (1 trials) and "Cerebrovascular Accident" (1 trials). Many other conditions were trialed in "Chattanooga Neurology Associates (Erlanger Hospital)" in a lesser frequency.
Clinical Trials Intervention Types at Chattanooga Neurology Associates (Erlanger Hospital)
Most popular intervention types in "Chattanooga Neurology Associates (Erlanger Hospital)" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "YM872 (zonampanel)" (1 trials) and "YM872 (zonampanel), t-PA (alteplase)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chattanooga Neurology Associates (Erlanger Hospital)
The vast majority of trials in "Chattanooga Neurology Associates (Erlanger Hospital)" are
2 trials for "All" genders.
Clinical Trials Status at Chattanooga Neurology Associates (Erlanger Hospital)
Currently, there are NaN active trials in "Chattanooga Neurology Associates (Erlanger Hospital)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Chattanooga Neurology Associates (Erlanger Hospital),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chattanooga Neurology Associates (Erlanger Hospital), 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".